Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Debates in Therapeutics 2009
Track:
Educational Sessions (CE)
Program Code: 205-L01
Date: Monday, December 7, 2009
Time: 2:00 PM to 5:00 PM EST
Location:
3104 - Lido
MEETING PLANNING ASSOCIATE:
Ms. Sandra Oh Clarke, RPh, Director, Section of Clinical Specialists and Scientists, American Society of Health-System Pharmacists
PRESENTER(S):
Dr. Snehal Bhatt, PharmD, BCPS, Assistant Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences
Ericka Breden, PharmD, BCPP, Clinical Pharmacy Specialist - Psychiatry, Virginia Commonwealth University Health System Peter (Pete) Johnson, PharmD, BCPS, Assitant Professor of Pharmacy Practice, University of Oklahoma College of Pharmacy Samuel Johnson, PharmD, BCPS (AQ-Cardiology), Clinical Pharmacy Specialist - Cardiology, Kaiser Permanente Colorado W. Klugh Kennedy, PharmD, BCPP, Clinical Associate Professor of Pharmacy and Psychiatry, Mercer University Dr. Cathy Poon, PharmD, Associate Professor of Clinical Pharmacy and Interim Chair, Philadelphia College of Pharmacy
Dr. Rowena Schwartz, PharmD, BCOP, Director of Oncology Pharmacy, The Johns Hopkins Hospital
Anne Spencer, PharmD, BCPS (AQ-Cardiology), Cardiac Care Pharmacy Specialist, Roper Saint Francis Healthcare
Description
Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists
ACPE Activity #204-000-09-205-L01P
3.0 Contact Hours / Knowledge-based
Educational Content: Level 3
Moderator: Rowena N. Schwartz, PharmD, BCOP, Director of Oncology Pharmacy, The Johns Hopkins Hospital, Baltimore, MD
2:00 p.m. - 2:10 p.m.
Announcements
2:10 p.m. - 2:50 p.m.
UTI Prophylaxis in the Pediatric Population
Cathy Y. Poon, PharmD, Associate Professor of Clinical Pharmacy and Vice Chair of Didactic Education, Philadelphia College of Pharmacy, Philadelphia, PA
Peter N. Johnson, PharmD, BCPS, Assistant Professor of Pharmacy Practice, University of Oklahoma College of Pharmacy, Oklahoma City; and Adjunct Assistant Professor of Pediatrics, University of Oklahoma College of Medicine, Oklahoma City
2:50 p.m. - 3:30 p.m.
Role of Surrogate Endpoints in Cardiovascular Medication Trials
Joel C. Marrs, PharmD, BCPS, Assistant Professor, University of Colorado Denver, Anschutz Medical Campus, School of Pharmacy, Aurora
Samuel Johnson, PharmD, BCPS (AQ-Cardiology), Clinical Pharmacy Specialist — Cardiology, Kaiser Permanente, Denver, CO
3:30 p.m. - 4:10 p.m.
Dosing of Medications Used in the Treatment of Fibromyalgia
Ericka L. Breden, PharmD, BCPP, Clinical Pharmacy Specialist - Psychiatry, Virginia Commonwealth University Health System, Richmond
W. Klugh Kennedy, PharmD, BCPP, Clinical Associate Professor of Pharmacy Practice, COPHS; and Associate Professor of Psychiatry and Behavorial Medicine, College of Medicine, Mercer University College of Pharmacy and Health Sciences, Department of Behavorial Medicine, Savannah, GA
4:10 p.m. - 4:50 p.m.
Proton Pump and Clopidogrel: Are There Drug Interactions?
Snehal Bhatt, PharmD, Assistant Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston; and Clinical Pharmacist, Beth Israel Deaconess Medical Center, Boston, MA
Anne Spencer, PharmD, BCPS (AQ-Cardiology), Cardiac Care Pharmacy Specialist, Roper Saint Francis Healthcare, Charleston, SC
4:50 p.m. - 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
ACPE Activity #204-000-09-205-L01P
3.0 Contact Hours / Knowledge-based
Educational Content: Level 3
Moderator: Rowena N. Schwartz, PharmD, BCOP, Director of Oncology Pharmacy, The Johns Hopkins Hospital, Baltimore, MD
2:00 p.m. - 2:10 p.m.
Announcements
2:10 p.m. - 2:50 p.m.
UTI Prophylaxis in the Pediatric Population
Cathy Y. Poon, PharmD, Associate Professor of Clinical Pharmacy and Vice Chair of Didactic Education, Philadelphia College of Pharmacy, Philadelphia, PA
Peter N. Johnson, PharmD, BCPS, Assistant Professor of Pharmacy Practice, University of Oklahoma College of Pharmacy, Oklahoma City; and Adjunct Assistant Professor of Pediatrics, University of Oklahoma College of Medicine, Oklahoma City
2:50 p.m. - 3:30 p.m.
Role of Surrogate Endpoints in Cardiovascular Medication Trials
Joel C. Marrs, PharmD, BCPS, Assistant Professor, University of Colorado Denver, Anschutz Medical Campus, School of Pharmacy, Aurora
Samuel Johnson, PharmD, BCPS (AQ-Cardiology), Clinical Pharmacy Specialist — Cardiology, Kaiser Permanente, Denver, CO
3:30 p.m. - 4:10 p.m.
Dosing of Medications Used in the Treatment of Fibromyalgia
Ericka L. Breden, PharmD, BCPP, Clinical Pharmacy Specialist - Psychiatry, Virginia Commonwealth University Health System, Richmond
W. Klugh Kennedy, PharmD, BCPP, Clinical Associate Professor of Pharmacy Practice, COPHS; and Associate Professor of Psychiatry and Behavorial Medicine, College of Medicine, Mercer University College of Pharmacy and Health Sciences, Department of Behavorial Medicine, Savannah, GA
4:10 p.m. - 4:50 p.m.
Proton Pump and Clopidogrel: Are There Drug Interactions?
Snehal Bhatt, PharmD, Assistant Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston; and Clinical Pharmacist, Beth Israel Deaconess Medical Center, Boston, MA
Anne Spencer, PharmD, BCPS (AQ-Cardiology), Cardiac Care Pharmacy Specialist, Roper Saint Francis Healthcare, Charleston, SC
4:50 p.m. - 5:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
- Compare the pro and con sides of selected therapeutic issues.
- Discuss why therapeutic controversy may occur.
- Identify four therapeutic areas in which controversy may exist.
This session is a part of:
Handout Online
